CompletedACTRN12621001617853
Official study titleEffect of a single vs. multi-session intervention on anxiety and depression symptoms in adults: a randomised controlled trial
This study has finished and is no longer accepting participants.
In AustraliaDepression, AnxietyInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Macquarie University
CompletedACTRN12617001258347
Official study titleA Single-Center, Open-Label Pharmacokinetic (PK) Study in male smokers to Assess the PK Profile of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS2)
This study has finished and is no longer accepting participants.
In AustraliaAddictionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Chrono Therapeutics Australia PTY LTD
CompletedACTRN12616000824460
Official study titleA Single-Center, Randomized, Open-Label, Two-Period, Cross Over, Pharmacokinetic Study to Assess the Relative Bioavailability of Nicotine Delivered by the Chrono Quit Smoking Solution (CQSS1) versus NicoDerm (Registered Trademark) CQ (Registered Trademark) Patch in Smokers
This study has finished and is no longer accepting participants.
In AustraliaAddictionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Chrono Therapeutics Australia PTY LTD
CompletedACTRN12615000165583
Official study titleA stepped wedge cluster randomised controlled trial of a healthy lifestyle intervention for people attending residential substance abuse treatment
This study has finished and is no longer accepting participants.
In AustraliaMental healthInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- University of Wollongong
WithdrawnACTRN12620000053921
Official study titleAn optimisation trial of an SMS-based, brief intervention after hospitalisation for self-harm, a suicide attempt, or suicidal ideation, targeting proximal risk factors for self-harm and suicide.
This study was withdrawn before enrollment.
In AustraliaSuicidalityInterventional studyAges 16–65
- Countries
- Australia
- Sponsor
- University of New South Wales
CompletedNCT05455684
What is this study about?This study evaluated the safety and effectiveness of Aticaprant for people with depression.
This study has finished and is no longer accepting participants.
In AustraliaDepressionMedication studyAges 18–74
- Countries
- Australia, United States, Belgium, + 10 others
- Sponsor
- Janssen Research & Development, LLC
TerminatedNCT05518149
What is this study about?This study evaluates the safety and effectiveness of Aticaprant for people with depression.
This study ended early.
In AustraliaDepressionMedication studyAges 18–74
- Countries
- Australia, United States, France, + 18 others
- Sponsor
- Janssen Research & Development, LLC
CompletedACTRN12621001097831
What is this study about?This study evaluated the effectiveness of psychotherapy for people with depression.
This study has finished and is no longer accepting participants.
In AustraliaDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Swinburne University of Technology
TerminatedNCT00256997
Official study titlePragmatic Randomized Trial of Risperdal Consta Versus Oral Atypical Antipsychotics in Poorly Adherent Subjects With Schizophrenia in a Routine Care Setting
This study ended early.
In AustraliaSchizophreniaMedication studyAges 18–65
- Countries
- Australia, Canada, United Kingdom, + 1 other
- Sponsor
- Janssen-Ortho Inc., Canada
CompletedACTRN12621001365853
Official study titleA Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RLS103 (CBD-Technosphere® Inhalation Powder) in Healthy Adult Volunteers
This study has finished and is no longer accepting participants.
In AustraliaAnxietyInterventional studyAges 18–55
- Countries
- Australia
- Sponsor
- Receptor Life Sciences Australia Pty Ltd